IP Library Granted Patent US 8,846,684
Granted Patent B2
US 8,846,684 · App. 13/423,647 · Granted Sep 30, 2014

Arbovirus inhibitors and uses thereof

Inventors: Scott Larsen (South Lyon, MI); Janice Sindac (Ann Arbor, MI); Scott Barraza (Ann Arbor, MI); David J. Miller (Chelsea, MI)
Assignee: The Regents of The University of Michigan
C07D401/06C07D491/048C07D401/14C07D471/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,846,684
App. No.
13/423,647
Granted
Sep 30, 2014
Kind
B2
Abstract

The present invention relates to chemical compounds, methods for their discovery, and their therapeutic use. In particular, the present invention provides compounds as inhibitors of arboviruses.

Claims (21)

1. A composition comprising a compound having the Formula

including pharmaceutically acceptable salts;

wherein R 1 is selected from the group consisting of H, phenyl,

wherein R3 and R4 are the same or different, and are selected from the group consisting of H, C 1 -C 8 alkyl, C 0 -C 6 alkyl-aryl, C 0 -C 6 cycloalkyl-aryl, C 0 -C 6 -alkyl-heteroaryl, or together form a substituted cyclic alkyl amine of 4-8 atoms; wherein alkyl, cycloalkyl, aryl and heteroaryl may be optionally substituted;

and

wherein A is selected from the group consisting of CH and C—CH 3 .

2. The composition of claim 1 , wherein said compound is selected from the group consisting of

3. A pharmaceutical composition, comprising:

a) a compound as recited in claim 1 ; and

b) a pharmaceutically acceptable carrier.

4. A method of inhibiting the growth of an arbovirus, comprising contacting an arbovirus with a compound under conditions such that said compound inhibits the growth of said arbovirus, wherein the arbovirus is an alphavirus, wherein said compound is shown in the following structure:

including pharmaceutically acceptable salts;

wherein R 1 is selected from the group consisting of H, phenyl,

wherein R3 and R4 are the same or different, and are selected from the group consisting of H, C 1 -C 8 alkyl, C 0 -C 6 alkyl-aryl, C 0 -C 6 cycloalkyl-aryl, C 0 -C 6 -alkyl-heteroaryl, or together form a substituted cyclic alkyl amine of 4-8 atoms; wherein alkyl, cycloalkyl, aryl and heteroaryl may be optionally substituted;

and

wherein A is selected from the group consisting of CH and C—CH 3 .

5. The method of claim 4 , wherein said compound is selected from the group consisting of

6. The method of claim 4 , wherein said arbovirus is in a cell.

7. The method of claim 6 , wherein said cell is in an animal.

8. The method of claim 7 , wherein said animal exhibits symptoms of an arbovirus infection and said contacting with said compound results in a decrease or elimination of said symptoms of an arbovirus infection.

9. The method of claim 4 , wherein said alphavirus is selected from the group consisting of Sindbis virus, Semliki forest virus, O'nyong'nyong virus, Chikungunya virus, Mayaro virus, Ross River virus, Barmah Forest virus, Eastern equine encephalitis virus, Western equine encephalitis virus, and Venezuelan equine encephalitis virus.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 1, 2012
From: LARSEN, SCOTT; SINDAC, JANICE; BARRAZA, SCOTT; MILLER, DAVID J.
To: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Reel/Frame 028303/0469 →
CONFIRMATORY LICENSE Recorded Apr 2, 2012
From: UNIVERSITY OF MICHIGAN
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 027970/0324 →
Continuity (2)
Provisional Application 61470038 · Mar 31, 2011
Related Publication 20120252807A1 · Oct 4, 2012